Admission Date:  [**2100-9-17**]              Discharge Date:   [**2100-9-28**]  Date of Birth:  [**2032-1-23**]             Sex:   M  Service: MEDICINE  Allergies: Cefazolin / Hydromorphone  Attending:[**First Name3 (LF) 2024**] Chief Complaint: Acute on chronic fatigue/hypotension/productive cough  Major Surgical or Invasive Procedure: arterial line placement  History of Present Illness: 68 y/o gentleman with metastatic renal cell cancer to lungs, acute on chronic fatigue and SOB, presented to ED with abdominal pain.
He recently stopped Pavluzimab on Tuesday, to start Sutinib this week.
Patient recieved 2 units of PRBC and 2L NS.
He also recieved Vancomycin 1 gram IV, Zosyn 4.5 grams IV and Levaquin 750 mg IV for possible PNA.
He also was started on levophed 0.09 given BP was still in 90s/40s.
He underwent thoracentesis which was negative for malignancy and bronchoscopy which revealed no endobronchial lesions.
He returned on [**2099-9-9**] for an elective thoracoscopy, pleural biopsy, talc pleurodesis, and pleurex catheter placement.
His pleurex catheter was removed on [**2099-9-15**].
He underwent laparoscopic nephrectomy on [**2099-9-21**] and pathology revealed renal cell carcinoma, conventional clear cell type, grade II, greatest dimension 7.5cm.
He enrolled in clinical trial 08-219, comparing pazopanib vs. sunitinib for locally advanced or metastatic RCC, on [**2099-11-17**] and was randomized to receive pazopanib.
Treatment was held from [**2100-1-19**] to [**2100-2-2**] for grade 3 elevation in his ALT (grade 2 in AST).
His pazopanib was on hold from [**7-9**] thru [**2100-7-28**] because he needed urgent dental surgery including bone removal.
-History of recurrent malignant pleural effusion, S/P right pleurodesis.
-Hypthyroidism, started on levothyroxine two days ago -Hypertension -Severe dermatitis reaction, which was thought secondary to Ancef prior to his pleuroscopy  Social History: Married, has 2 daughters one is a nurse at [**Hospital1 **].
PSYCH: Listens and responds to questions appropriately, pleasant  Pertinent Results: [**2100-9-16**] 09:35PM   HAPTOGLOB-372* [**2100-9-16**] 09:35PM   ALBUMIN-3.0* CALCIUM-11.2* PHOSPHATE-3.3 MAGNESIUM-2.1 [**2100-9-16**] 09:35PM   cTropnT-0.01 [**2100-9-16**] 09:35PM   CK-MB-NotDone [**2100-9-16**] 09:35PM   ALT(SGPT)-8 AST(SGOT)-13 CK(CPK)-16* ALK PHOS-57 TOT BILI-0.4 [**2100-9-16**] 09:35PM   estGFR-Using this [**2100-9-16**] 09:35PM   GLUCOSE-103 UREA N-23* CREAT-1.5* SODIUM-133 POTASSIUM-5.3* CHLORIDE-101 TOTAL CO2-25 ANION GAP-12 [**2100-9-16**] 09:40PM   RET AUT-2.1 [**2100-9-16**] 09:40PM   PLT COUNT-412 [**2100-9-16**] 09:40PM   NEUTS-77.9* LYMPHS-15.7* MONOS-5.0 EOS-0.8 BASOS-0.5 [**2100-9-16**] 09:40PM   WBC-5.4 RBC-2.58* HGB-7.8* HCT-23.7* MCV-92 MCH-30.4 MCHC-33.1 RDW-17.3* [**2100-9-16**] 09:43PM   GLUCOSE-105 LACTATE-1.7 NA+-133* K+-5.0 CL--100 TCO2-24 [**2100-9-17**] 01:46AM URINE  RBC-0 WBC-0-2 BACTERIA-OCC YEAST-NONE EPI-0 [**2100-9-17**] 01:46AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG [**2100-9-17**] 01:46AM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]->1.050 [**2100-9-17**] 03:40AM   RET AUT-1.7 .
Echo: poor technical quality due to patient's body habitus.
Patient did not require further transfusions throughout hospital course.
In the ICU the patient initially required norepinephrine for blood pressure support but was weaned off of this on [**2100-9-19**].
Otherwise, the patient's blood presure was supported with IV fluids and by holding his home antihypertensives.
The patient was treated with vancomycin, Zosyn, and ciprofloxacin given frequent contact with healthcare.
Ciprofloxacin was discontinued on [**2100-9-20**].
Vancomycin and zosyn were transitioned to po levofloxacin to complete a course of antibiotic therapy for community acquired pneumonia.
Orthostasis resolved with fluids on discharge.
Calcium again trended up while on the floors and patient was given iv pamidronate.
Metastatic renal cell carcinoma:  Patient is s/p laparoscopic nephrectomy on [**2099-9-21**] and pazopanib therapies.
Patient was started on Sutinib and this is to be continued while in rehab.
- Please continue Sutinib - Please check weekly CBC .
Hypothyroidism: Prior to admission patient recently started on levothyroxine.
No changes were made to his home dose of levothyroxine as he had only been recently started on this medication.
Medications on Admission: Fentanyl 50 mcg/hour Patch Furosemide 20 mg [**Hospital1 **] PRN, has only taken two doses Levothyroxine 25 mcg daily Lidocaine-Prilocaine 2.5 %-2.5 % Cream apply 1 hour prior porta-cath access as directed Lisinopril 5 mg daily Lorazepam 1 mg q8h PRN anxiety/nausea Megestrol 400 mg daily Methylphenidate 5 mg [**Hospital1 **] Oxycodone 2.5 - 5 mg by mouth q 2hours as needed for trouble breathing; pain Docusate Sodium 100 mg [**Hospital1 **] Multivitamin daily Polyethylene Glycol [**Hospital1 **] PRN Senna 17.2 mg PRN  Discharge Disposition: Extended Care  Facility: [**Hospital6 459**] for the Aged - [**Location (un) 550**]  Discharge Diagnosis: Primary: Anemia Pneumonia Acute on Chronic Renal Failure Metastatic Renal Cancer   Discharge Condition: Stable: T 97.8, BP 119/55, O2 96/RA   Discharge Instructions: You were seen in the hospital for your fatigue.
While in the emergency room you received blood transfusion.
You were in the ICU, and were treated with iv antibiotics and iv fluids.
We have stopped your lisinopril and lasix because your blood pressure was low, please follow up with your PCP to decide when to restart these medications 2.
Please take levofloxacin to treat your pneumonia until [**9-26**].
We have started you on an iron supplement.
[**Last Name (STitle) **] on [**2100-10-4**] 9:45am, she will decide if you should be restarted on lisinopril and lasix.
She will also follow up on your TSH and determine if your synthroid dose should be changed.
